Immucell Corp /DE/ SEC filings ICCC
Immucell Corp /DE/ has 795 filings in SEC EDGAR's recent list, going back to Aug 3, 1995. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B2 | Prospectus | Apr 10, 2024 | — |
| 424B2 | Prospectus | Apr 10, 2024 | — |
| S-3 | Shelf registration | Apr 1, 2024 | — |
| S-8 | Employee stock plan registration | Jul 13, 2023 | — |
| 424B5 | Prospectus supplement | Apr 16, 2021 | — |
| S-8 | Employee stock plan registration | Mar 27, 2020 | — |
| 424B5 | Prospectus supplement | Mar 27, 2019 | — |
| 424B5 | Prospectus supplement | Mar 26, 2019 | — |
| 424B3 | Prospectus | Nov 29, 2018 | — |
| S-3 | Shelf registration | Nov 20, 2018 | — |
| 424B5 | Prospectus supplement | Dec 19, 2017 | — |
| 424B5 | Prospectus supplement | Jul 27, 2017 | — |
| 424B3 | Prospectus | Dec 15, 2016 | — |
| S-3/A | Amendment to form s-3 | Dec 5, 2016 | — |
| S-3 | Shelf registration | Nov 16, 2016 | — |
| 424B5 | Prospectus supplement | Jan 29, 2016 | — |
| 424B5 | Prospectus supplement | Jan 28, 2016 | — |
| S-3/A | Amendment no. 1 to registration statement | Nov 5, 2015 | — |
| S-3 | Shelf registration | Oct 27, 2015 | — |
| S-8 | Employee stock plan registration | Jun 23, 2010 | — |
| S-8 | Employee stock plan registration | Jul 20, 2001 | — |
| S-8 | Employee stock plan registration | Apr 19, 1996 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- ICCC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Portland, ME
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 811641
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.